MedPath

Evaluation of the effect of preprandial ingestion of novel glucomannan containing food on human health.

Not Applicable
Conditions
healthy subjects or diabetes mellitus controlled under HbA1c 7.0% (NGSP)
postprandial hyperglycemia
E11.9
Registration Number
JPRN-jRCTs031190087
Lead Sponsor
Yoshida Akihiro
Brief Summary

G1 fiber may be expected to have an effect of suppressing blood sugar elevation in people with metabolic syndrome

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
20
Inclusion Criteria

healthy subjects or diabetes patients with HbA1c <7%

Exclusion Criteria

diabetes patients with HbA1c >= 7%
diabetes patients under treatment
patients with severe constipation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath